Navigation Links
NuView Life Sciences Awarded Grants Under the Patient Protection and Affordable Care Act of 2010
Date:11/4/2010

PARK CITY, Utah, Nov. 4, 2010 /PRNewswire/ -- NuView Life Sciences, Inc ("NuView"), a biopharmaceutical company specializing in the development of proprietary target specific biomarkers for utilization with Positron Emission Tomography ("PET") imaging procedures, announced today that its applications for the Qualifying Therapeutic Discovery Project Credit ("Therapeutic Credit") were approved.

The grants totaling just over $1.2 million dollars were awarded to NuView for further development and validation of several of the Company's projects. The diagnostic imaging biomarker projects that were approved under the Therapeutic Credit program are for breast cancer, lymphoma, cancer proliferation and cardiovascular imaging.

"We are very pleased that the underlying science of our pipeline candidates has been recognized under the Therapeutic Credit program, further enabling the clinical advancement of these projects," commented Paul Crowe, Chairman and Chief Executive Officer of NuView.

About the Qualifying Therapeutic Discovery ProjectThe Qualifying Therapeutic Discovery Project tax credit or grant is provided under new section 48D of the Internal Revenue Code (IRC), enacted as part of the Patient Protection and Affordable Care Act of 2010 (P.L. 111-148). The tax credit or grant is a benefit targeted to therapeutic discovery projects that show a reasonable potential to:

  • Result in new therapies to treat areas of unmet medical need or prevent, detect or treat chronic or acute diseases and conditions;
  • Reduce the long-term growth of health care costs in the United States, or significantly advance the goal of curing cancer within 30 years.

  • Allocation of the credit or grant also takes into consideration which projects show the greatest potential to create and sustain high-quality, high-paying U.S. jobs and to advance U.S. competitiveness in life, biological and medical sciences. The credit or grant is only available to companies with no more than 250 employees. The total amount of credits available to all companies is limited to $1 billion.

    About NuView Life Sciences, IncNuView Life Sciences, Inc is a privately held Utah based biopharmaceutical company developing target specific biomarkers for diagnostic Positron Emission Tomography ("PET") imaging procedures. The Company's clinical stage pipeline includes several proprietary products for diagnosing cancer and heart disease.  Please visit our website at www.nuviewinfo.com.For more information please contact:

    Rob Alday NuView Life Sciences, IncTel.  435-647-9758Fax. 435-647-5602info@nuviewinfo.com
    '/>"/>

    SOURCE NuView Life Sciences, Inc
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Coronado Biosciences, Inc. Announces Completion of Financings, Management Changes and Development Update
    2. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
    3. Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions
    4. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
    5. Pittsburgh Life Sciences Greenhouse and Innovation Works Announce Investments in Ib2C™
    6. Indiana Life Sciences Start Ups Garner More than $1.5 Million in Competitive Federal Funding
    7. Neurocrine Biosciences Reports Third Quarter 2010 Results
    8. Neurocrine Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
    9. Adeona CEO to Provide Keynote Address at the 2010 MichBio Expo & Conference Emerging Biosciences Showcase
    10. Caliper Life Sciences Signs Co-Marketing Pact with Illumina to Improve Sequencing Workflows
    11. Caliper Life Sciences Expands Offering for Next Generation Sequencing Workflows
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/29/2017)... 29, 2017  The leader in accelerated orthodontics, OrthoAccel ... Sam Daher , Manal Ibrahim , Kenji ... will be the featured microlecture presenters at the AcceleDent ... of Orthodontists (AAO) Annual Session, April 21-25, 2017. Orthodontists ... beginning daily at 11:20 a.m. On the opening morning ...
    (Date:3/29/2017)... March 29, 2017 Transparency ... which provides an exhaustive study of the U.S. substance ... 242 companies are functional in this market at ... the leading companies, such as GlaxoSmithKline Plc., Pfizer ... aggressively on various marketing strategies to increase their ...
    (Date:3/29/2017)... -- Varian Medical Systems (NYSE: VAR ) announced ... of fiscal year 2017 following the close of regular trading ... followed by a teleconference available to all interested parties at ... the conference call webcast will be available on the company ... and replay: ...
    Breaking Medicine Technology:
    (Date:3/29/2017)... ... 2017 , ... In the United States alone, up to 36% of primary ... of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are known ... effective treatment options, the San Diego Gamma Knife Center offers a precision-medicine ...
    (Date:3/29/2017)... ... , ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower program ... students who have participated in the program every summer. The 2017 Serve, Learn, ... for enrollment. Visit http://www.ghana.yfiexperience.org to learn more. , “I have sent ...
    (Date:3/29/2017)... ... 29, 2017 , ... The Wall Centre Dental team is ... from Burnaby, BC. Patients in need of experienced orthodontics, laser dentistry, porcelain veneers, ... esteemed team at Wall Centre Dental. Drs. Parviz Roshan, Siamak Tehrani, Milton Reskovich ...
    (Date:3/29/2017)... ... March 29, 2017 , ... How big is the ... and who are the most active developers? , In the first independently ... Estate Insights (HREI) found that outpatient medical real estate development projects totaling nearly ...
    (Date:3/29/2017)... Ca (PRWEB) , ... March 29, 2017 , ... ... process in many scientific laboratories. The assembly protocols involve many repetitive steps and ... suited for automation, which enables the high-throughput needed, and results in a lower ...
    Breaking Medicine News(10 mins):